The Weird History of Statins: Mold, Muscle Pain, and the Nocebo Effect

I knew statins worked. I did not know how strange the origin story was.

How statins started with mold

The first statin came from Akira Endo, a Japanese biochemist who grew up fascinated by fungi and was inspired by the discovery of penicillin. After spending time in New York in the 1960s, he was struck by how common heart attacks seemed compared with rural Japan. Cholesterol was becoming a serious suspect in heart disease, and Endo wondered whether mold might contain a compound that could block the body’s cholesterol production.

He screened thousands of fungal samples and eventually found compactin, later called mevastatin, in mold from rice collected at a Kyoto grain shop. That work led to lovastatin, the first commercial statin, and eventually to one of the most important drug classes in cardiovascular medicine.

How statin fear spread

The fear story is almost as interesting. Statin skepticism did not start on TikTok or in YouTube comments. It has been around for decades, fed by claims that cholesterol risk was exaggerated and statins were broadly harmful. The internet just made those claims louder.

What the SAMSON trial found

The muscle-pain question is where this gets practical. Symptoms can be real, but not always caused by the drug. In the SAMSON trial, people who had already quit statins because of side effects rotated through months of atorvastatin, placebo, and no pills. Symptom scores were almost the same on statin and placebo, and the researchers calculated a nocebo ratio of 0.90.

That means about 90% of the symptom burden people attributed to the statin was also triggered by placebo.

That does not mean symptoms are fake. It means bodies are noisy, expectations matter, and aging or training aches can get misattributed to a pill. The better move is not panic or quiet quitting. It is a real conversation with your doctor about dose, statin type, risk, LDL or apoB target, and add-on options.

My own approach

For me, that currently means low-dose rosuvastatin plus ezetimibe. Not because I think medication replaces training, diet, sleep, or blood pressure control. It does not. But cardiovascular risk is one of those places where “I’ll just lifestyle harder” can become a comforting excuse.

Sometimes the least dramatic answer is the one that actually lowers risk.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top